Submitted:
22 December 2025
Posted:
23 December 2025
You are already at the latest version
Abstract
Keywords:
1. Introduction
1.1. Background/Rationale
1.2. Objectives
2. Methods
2.1. Study Design, Setting and Participants
2.2. Variables
2.3. Statistical Methods
3. Results
3.1. Participants
3.2. Descriptive Data
3.3. Outcome Data
3.4. Main Results
4. Discussion
4.1. Key Results
4.2. Limitations
4.3. Interpretation
4.4. Generalizability
Author Contributions
Funding
Ethics Approval and Consent to Participate
Availability of Data and Materials
Acknowledgments
Conflicts of Interest
Abbreviations
| BS | Blood Stream infections |
| CCI | Charlson Comorbidity Index |
| CHF | Congestive Heart Failure |
| HM | History of Hemiplegia, |
| CKD | Chronic Kidney Disease |
| COPD | Chronic Obstructive Pulmonary Disease |
| CVA | Acute Cerebrovascular Accidents or Transient Ischemic Attacks |
| D | Dementia |
| DM | Diabetes Mellitus |
| ED | Emergency Department |
| EDLos | Emergency Department length of stay |
| HLoS | Hospital length of stay |
| GI | Gastro Interstinal Infections |
| GTD | Connective Tissue diseases, |
| PUD | Peptic Ulcer Disease |
| HAI | Healthcare Associated Infection |
| HR | Hazard ratio |
| L | Lymphoma and Leukaemia |
| LD | Liver Disease |
| MI | History of Myocardial Infarction |
| NEWS | National Early Warning Score |
| PN | Pneumonia |
| PVD | Peripheral Vascular Disease |
| ROC | Receiver Operating Characteristic |
| SS | Surgical Site infection |
| SST | Skin and Soft Tissue infections |
| ST | Solid Tumours |
| UTI | Urinary tract infections |
Appendix A
| Comorbidities | Total, No. (%) | Dead, No. (%) | Alive, No. (%) | OR (95% CI) | P-value |
|---|---|---|---|---|---|
| Sex (males) | 12,694 (50.2) | 1,177 (50.1) | 11,517 (50.2) | 0.99 (0.91–1.08) | 0.896 |
| D | 4,157 (16.4) | 459 (19.5) | 3,698 (16.1) | 1.26 (1.13–1.41) | <0.001 |
| COPD | 3,657 (14.5) | 534 (22.7) | 3,123 (13.6) | 1.86 (1.68–2.07) | <0.001 |
| DM | 3,371 (13.3) | 671 (28.5) | 2,700 (11.8) | 2.99 (2.71–3.30) | <0.001 |
| CKD | 2,678 (10.6) | 457 (19.4) | 2,221 (9.7) | 2.25 (2.01–2.52) | <0.001 |
| CVA | 2,669 (10.6) | 345 (14.7) | 2,324 (101) | 1.53 (1.35–1.72) | <0.001 |
| MI | 2,168 (8.6) | 218 (9.3) | 1,950 (8.5) | 1.10 (0.95–1.27) | 0.203 |
| CHF | 2,166 (8.6) | 344 (14.6) | 1,822 (7.9) | 1.99 (1.76–2.25) | <0.001 |
| HM | 1,881 (7.4) | 257 (10.9) | 1,624 (7.1) | 1.61 (1.40–1.85) | <0.001 |
| LD | 1,656 (6.5) | 203 (6.8) | 1,453 (6.3) | 1.40 (1.20–1.63) | <0.001 |
| CTD | 1,545 (6.1) | 153 (6.5) | 1,392 (6.1) | 1.08 (0.91–1.28) | 0.396 |
| PVD | 517 (2.0) | 62 (2.6) | 455 (2.0) | 1.34 (1.02–1.75) | 0.033 |
| PUD | 470 (1.91) | 52 (2.2) | 418 (1.8) | 1.22 (0.91–1.63) | 0.183 |
| L | 406 (1.6) | 63 (2.7) | 343 (1.5) | 1.81 (1.38–2.38) | <0.001 |
| Ly | 142 (0.6) | 20 (0.8) | 1 22 (0.5) | 1.60 (1.00–2.58) | 0.001 |
| AIDS | 13 (0.1) | 0 (0.0) | 13 (0.6) | NA | NA |
| ICD-9 Diagnosis codes | Total, No. | Dead, No. (%) | Alive, No. (%) | OR (95% CI) | p-value |
|---|---|---|---|---|---|
| Diseases of the Respiratory System 460-519) | 5,478 (21.7) | 910 (38.7) | 4,568 (19.9) | 2.54 (2.32–2.78) | <0.001 |
| Diseases of the Circulatory System (390-459) | 5,195 (20.5) | 395 (16.8) | 4,800 (20.9) | 0.76 (0.68–0.85) | <0.001 |
| Diseases of the Digestive System (520-579) | 3,343 (13.2) | 171 (7.3) | 3,172 (13.8) | 0.49 (0.42–0.57) | <0.001 |
| Injury and Poisoning (800-999) | 2,605 (10.3) | 65 (2.8) | 2,540 (11.1) | 0.23 (0.18–0.29) | <0.001 |
| Diseases of the Genitourinary System (580-629) | 2,026 (8.0) | 139 (5.9) | 1,887 (8.2) | 0.70 (0.59–0.84) | <0.001 |
| Infectious and Parasitic Diseases (001-139) | 1,926 (7.6) | 348 (14.8) | 1,578 (6.9) | 2.35 (2.08–2.66) | <0.001 |
| Neoplasms (140-239) | 1,135 (4.5) | 185 (7.9) | 950 (4.1) | 1.98 (1.68–2.33) | <0.001 |
| Symptoms, Signs, & Lab. Findings (780 – 799) | 981 (3.9) | 50 (2.1) | 931 (4.1) | 0.51 (0.39–0.68) | <0.001 |
| Mental Disorders (290-319) | 623 (2.5) | 3 (0.1) | 620 (2.7) | 0.05 (0.01–0.14) | <0.001 |
| Diseases of the Nervous System (320-389) | 490 (1.9) | 26 (1.1) | 464 (2.0) | 0.54 (0.36–0.81) | 0.002 |
| Diseases of the Blood (280-289) | 483 (1.9) | 18 (0.8) | 465 (2.0) | 0.37 (0.23–0.60) | <0.001 |
| Endocrine, Nutritional, and Metabolic (240-279) | 339 (1.3) | 24 (1.0) | 315 (1.4) | 0.74 (0.49–1.12) | 0.157 |
| Diseases of the Musculoskeletal System (710-739) | 230 (0.9) | 11 (0.5) | 219 (1.0) | 0.49 (0.27–0.89) | 0.018 |
| Complications of Pregnancy (630-679) | 224 (0.9) | 0 (0.0) | 224 (1.0) | NA | NA |
| Diseases of the Skin (680-709) | 112 (0.4) | 4 (0.2) | 108 (0.5) | 0.36 (0.13–0.98) | 0.037 |
| External Causes (E, V codes) | 70 (0.3) | 1 (0.1) | 69 (0.3) | 0.14 (0.02–1.02) | 0.023 |
| Congenital Malformations (740-759) | 20 (0.1) | 0 (0.0) | 20 (0.1) | NA | NA |


References
- Sklar DP, Crandall CS, Loeliger E, Edmunds K, Paul I, Helitzer DL. Unanticipated Death After Discharge Home From the Emergency Department. Ann Emerg Med [Internet]. 2part007 June [cited 2025 Jan 10];49(6):735–45. Available from: https://linkinghub.elsevier.com/retrieve/pii/S019606440602542X.
- Adal O, Tsehay YT, Ayenew B, Abate TW, Mekonnen GB, Mulatu S, et al. The burden and predictors of hospital-acquired infection in intensive care units across Sub-Sahara Africa: systematic review and metanalysis. BMC Infect Dis [Internet]. 2025 Apr 29 [cited 2025 June 19];25:634. Available online: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12042380/. [CrossRef]
- Barrasa-Villar, JI; Aibar-Remón, C; Prieto-Andrés, P; Mareca-Doñate, R; Moliner-Lahoz, J. Impact on Morbidity, Mortality, and Length of Stay of Hospital-Acquired Infections by Resistant Microorganisms. Clin Infect Dis Off Publ Infect Dis Soc Am 2017, 65(4), 644–52. [Google Scholar] [CrossRef]
- Evans, S. Could a risk-assessment tool prevent hospital-acquired pneumonia? Br J Nurs Mark Allen Publ 2018, 27(7), 402–4. [Google Scholar] [CrossRef]
- McFee, RB. Nosocomial or Hospital-acquired Infections: An Overview. Dis Mon [Internet] 2009 July [cited 2025 June 19], 55(7), 422–38. Available online: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7094512/. [CrossRef] [PubMed]
- Quach, C; McArthur, M; McGeer, A; Li, L; Simor, A; Dionne, M; et al. Risk of infection following a visit to the emergency department: a cohort study. CMAJ Can Med Assoc J [Internet] 2012 Mar 6 [cited 2025 Oct 21], 184(4), E232–9. Available online: https://pmc.ncbi.nlm.nih.gov/articles/PMC3291696/. [CrossRef]
- Williams, B. The National Early Warning Score: from concept to NHS implementation. Clin Med Lond Engl. 2022, 22(6), 499–505. [Google Scholar] [CrossRef] [PubMed]
- Grafstein, E; Unger, B; Bullard, M; Innes, G. Canadian Emergency Department Information System (CEDIS) Presenting Complaint List (Version 1.0). CJEM 2003, 5(1), 27–34. [Google Scholar] [CrossRef]
- Huang Y qun, Gou R, Diao Y shu, Yin Q hua, Fan W xing, Liang Y ping, et al. Charlson comorbidity index helps predict the risk of mortality for patients with type 2 diabetic nephropathy. J Zhejiang Univ Sci B 2014, 15(1), 58–66.
- Fabbri, A; Tascioglu, AB; Bertini, F; Montesi, D. Overnight Stay in the Emergency Department and In-Hospital Mortality Among Elderly Patients: A 6-Year Follow-Up Italian Study. J Clin Med. 2025, 14(9), 2879. [Google Scholar] [CrossRef] [PubMed]
- Charlson, ME; Pompei, P; Ales, KL; MacKenzie, CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987, 40(5), 373–83. [Google Scholar] [CrossRef]
- Kärki T, Plachouras D, Cassini A, Suetens C. Burden of healthcare-associated infections in European acute care hospitals. Wien Med Wochenschr [Internet]. 2019 Feb 1 [cited 2025 Mar 3];169(1):3–5. [CrossRef]
- Point prevalence survey of healthcare-associated infections and antimicrobial use in European acute care hospitals – 2022-2023 [Internet]. 2024 [cited 2025 Mar 13]. Available online: https://www.ecdc.europa.eu/en/publications-data/PPS-HAI-AMR-acute-care-europe-2022-2023.
- Agresti A, Caffo B. Simple and Effective Confidence Intervals for Proportions and Differences of Proportions Result from Adding Two Successes and Two Failures. Am Stat [Internet]. 2000 Nov 1 [cited 2025 Jan 10];54(4):280–8. [CrossRef]
- Mirhaghi, A; Heydari, A; Mazlom, R; Ebrahimi, M. The Reliability of the Canadian Triage and Acuity Scale: Meta-analysis. North Am J Med Sci 2015, 7(7), 299–305. [Google Scholar] [CrossRef]
- Fluss, R; Faraggi, D; Reiser, B. Estimation of the Youden Index and its Associated Cutoff Point. Biom J [Internet] Available from. 2005 [cited 2025 Jan 13], 47(4), 458–72. [Google Scholar] [CrossRef]
- Ali, H; Salleh, MNM; Hussain, K; Ahmad, A; Ullah, A; Muhammad, A; et al. A review on data preprocessing methods for class imbalance problem. Int J Eng.
- Raoofi S, Kan FP, Rafiei S, Hosseinipalangi Z, Mejareh ZN, Khani S, et al. Global prevalence of nosocomial infection: A systematic review and meta-analysis. PLOS ONE [Internet]. 2023 Jan 27 [cited 2025 June 20];18(1):e0274248. Available online: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0274248. [CrossRef]
- Schuttevaer, R; Boogers, W; Brink, A; van Dijk, W; de Steenwinkel, J; Schuit, S; et al. Predictive performance of comorbidity for 30-day and 1-year mortality in patients with bloodstream infection visiting the emergency department: a retrospective cohort study. BMJ Open 2022, 12(4), e057196. [Google Scholar] [CrossRef] [PubMed]
- Yu XL, Zhou LY, Huang X, Li XY, Pan QQ, Wang MK, et al. Urgent call for attention to diabetes-associated hospital infections. World J Diabetes [Internet]. 2024 Aug 15 [cited 2025 June 20];15(8):1683–91. Available online: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11346093/. [CrossRef]
- Deng B, Li P, Liu Y, Xie J, Huang Y, Sun Q, et al. Investigation of hospital-acquired infections prevalence and analysis of influencing factors: a case study of a specialized infectious disease hospital in Chongqing, 2017–2023. Front Public Health [Internet]. 2024 Oct 17 [cited 2025 Nov 6];12:1417645. Available online: https://pmc.ncbi.nlm.nih.gov/articles/PMC11524860/. [CrossRef] [PubMed]
- McPhail, S; Swann, R; Johnson, SA; Barclay, ME; Abd Elkader, H; Alvi, R; et al. Risk factors and prognostic implications of diagnosis of cancer within 30 days after an emergency hospital admission (emergency presentation): an International Cancer Benchmarking Partnership (ICBP) population-based study. Lancet Oncol 2022, 23(5), 587–600. [Google Scholar] [CrossRef] [PubMed]
- Battaglia CC, Hale K. Hospital-Acquired Infections in Critically Ill Patients With Cancer. J Intensive Care Med [Internet]. 2019 July 1 [cited 2025 Nov 12];34(7):523–36. [CrossRef] [PubMed]
- van Mourik MSM, van Duijn PJ, Moons KGM, Bonten MJM, Lee GM. Accuracy of administrative data for surveillance of healthcare-associated infections: a systematic review. BMJ Open [Internet]. 2015 Aug 27 [cited 2025 July 24];5(8):e008424. Available online: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4554897/. [CrossRef]
- Kakehi, E; Uehira, R; Ohara, N; Akamatsu, Y; Osaka, T; Sakurai, S; et al. Utility of the New Early Warning Score (NEWS) in combination with the neutrophil-lymphocyte ratio for the prediction of prognosis in older patients with pneumonia. Fam Med Community Health 2023, 11(2), e002239. [Google Scholar] [CrossRef]
- Liang, SY; Theodoro, DL; Schuur, JD; Marschall, J. Infection Prevention in the Emergency Department. Ann Emerg Med [Internet] 2014 Sept [cited 2025 Mar 6], 64(3), 299–313. Available online: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4143473/. [CrossRef] [PubMed]
- Magill, SS; Edwards, JR; Bamberg, W; Beldavs, ZG; Dumyati, G; Kainer, MA; et al. Multistate point-prevalence survey of health care-associated infections. N Engl J Med. 2014, 370(13), 1198–208. [Google Scholar] [CrossRef] [PubMed]
- Stewart, S; Robertson, C; Pan, J; Kennedy, S; Haahr, L; Manoukian, S; et al. Impact of healthcare-associated infection on length of stay. J Hosp Infect 2021, 114, 23–31. [Google Scholar] [CrossRef]
- Muehlschlegel S, Rajajee V, Wartenberg KE, Alexander SA, Busl KM, Creutzfeldt CJ, et al. Guidelines for Neuroprognostication in Critically Ill Adults with Moderate–Severe Traumatic Brain Injury. Neurocrit Care [Internet]. 2024 [cited 2025 June 17];40(2):448–76. Available online: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10959796/. [CrossRef]
- Nelson, RE; Nelson, SD; Khader, K; Perencevich, EL; Schweizer, ML; Rubin, MA; et al. The Magnitude of Time-Dependent Bias in the Estimation of Excess Length of Stay Attributable to Healthcare-Associated Infections. Infect Control Hosp Epidemiol 2015, 36(9), 1089–94. [Google Scholar] [CrossRef]



| Total, No. | Dead, No. (%) | Alive, No. (%) | OR (95% CI) | P-value | |
|---|---|---|---|---|---|
| Patients | 28,803 | 2,359 (9.3) | 22,930 (90.7) | -- | -- |
| Sex (males) | 12,694 (50.2) | 1,177 (50.1) | 11,517 (50.2) | 0.99 (0.91–1.08) | 0.896 |
| Age (years) | 78 [64–86] | 86 [79–91] | 77 [18 – 106] | -- | NS |
| 18 - 30 | 998 (3.9) | 3 (0.1) | 995 (4.3) | 0.03 (0.01–0.09) | <0.001 |
| 31 - 40 | 885 (3.5) | 8 (0.3) | 877 (3.8) | 0.09 (0.04–0.17) | <0.001 |
| 41 - 50 | 1,274 (5.0) | 19 (0.8) | 1,255 (5.5) | 0.14 (0.09–0.22) | <0.001 |
| 51 - 60 | 2,238 (8.8) | 64 (2.7) | 2,174 (9.5) | 0.27 (0.21–0.34) | <0.001 |
| 61 - 70 | 3,256 (12.9) | 175 (7.4) | 3,081 (13.4) | 0.52 (0.44–0.61) | <0.001 |
| 71 - 80 | 5,695 (22.5) | 418 (17.8) | 5,277 (23.0) | 0.72 (0.65–0.81) | <0.001 |
| >80 | 1[18–1060,934 (43.2) | 1,663 (70.8) | 9,271 (40.4) | 3.57 (3.25–3.91) | <0.001 |
| NEWS | |||||
| 0 - 3 | 21,317 (84.3) | 1,488 (63.3) | 19,829 (86.5) | 0.27 (0.25–0.30) | <0.001 |
| 4 - 6 | 2,258 (8.9) | 406 (17.3) | 1,852 (8.1) | 2.38 (2.11–2.67) | <0.001 |
| >6 | 1,705 (6.7) | 456 (19.4) | 1,249 (5.4) | 4.18 (3.72–4.70) | <0.001 |
| CCI | |||||
| 1 - 2 | 5,563 (22.1) | 66 (2.81) | 5,497 (24.0) | 0.09 (0.07–0.12) | <0.001 |
| 3 - 4 | 7,632 (30.2) | 512 (21.8) | 7,120 (31.0) | 0.62 (0.56–0.68) | <0.001 |
| >4 | 12,085 (47.8) | 1,772 (75.4) | 10,313 (45.0) | 3.75 (3.40–4.13) | <0.001 |
| HAI categories | No. = 2,141 | % | |
|---|---|---|---|
| Pneumonia (PN) | |||
| 485 | Bronchopneumonia, unspecified | 217 | 10.1 |
| 460 – 466 | Acute & lower respiratory tract infections | 115 | 5.4 |
| 486 | Pneumonia, unspecified | 162 | 7.6 |
| 480 | Viral pneumonia | 44 | 0.2 |
| 482-3, 484.0-7-8, 487-8 | Pneumonia due to another organism | 352 | 16.4 |
| 481 | Pneumococcal pneumonia | 29 | 0.1 |
| Total | 890 | 41.6 | |
| Urinary tract (UT) | |||
| 599.0 | Urinary infection (unspecified site) | 697 | 32.5 |
| 590.1 | Acute pyelonephritis | 24 | 0.1 |
| 996.64 | Infection due to urinary catheter | 13 | 0.1 |
| Total | 734 | 34.3 | |
| Blood Stream (BS) | |||
| 995.91, 995.92 | Sepsis | 181 | 8.4 |
| 038, 038.4 | Septicemia (including specific organisms) | 149 | 7.0 |
| 038.8, 038.9, 790.7 | Septicemia unspecified, bacteriemia | 139 | 5.6 |
| 038.0-1 | Septicemia due to Streptococcus | 98 | 4.6 |
| 038.2 | Septicemia due to Gram neg. bacteria | 1 | 0.0 |
| Total | 568 | 26.5 | |
| Gastrointestinal (GI) | |||
| 008.45 | Intestinal infection (Clostridium difficile) | 76 | 3.5 |
| 009.0-3 | Infectious enteritis, unspecified | 33 | 1.5 |
| 008.5x, 009.2, 099.3 | Other intestinal infections due to bacteria | 5 | 0.1 |
| Total | 114 | 5.3 | |
| Surgical Site (SS) | |||
| 996.6x | Infection due to internal prosthetic device | 33 | 1.5 |
| 998.5-9 | Other post-operative infection | 2 | 0.1 |
| 998.50-4, 998.51 | Post operative wound infection, | 12 | 0.1 |
| Total | 47 | 2.1 | |
| Skin & Soft Tissue (SST) | |||
| 680-686 | Other cellulitis and abscess | 40 | 0.2 |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2025 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license.
